CVS Health Corp vs Roblox Corp — how do they compare? CVS Health Corp trades at $85.29 (market cap $112.29B), while Roblox Corp trades at $46.02 (market cap $32.52B). The key difference: CVS Health Corp is far larger — about 3.5× Roblox Corp's market cap, and CVS Health Corp pays a 3.03% dividend while Roblox Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Roblox Corp for 93 Days on average.
| CVS | RBLX | |
|---|---|---|
Market Cap | $112.29B | $32.52B |
Volume | 7,763,676 | 14,552,045 |
Sector | Health | Technology |
52-Week High | $110.60 | $138.56 |
52-Week Low | $70.08 | $35.54 |
Typical Hold Time | 83 Days | 93 Days |
Enterprise Value | $174.64B | $31.34B |
Dividend Yield | 3.03% | — |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% on the day, with a bullish technical signal and strong analyst support. Recent earnings beats in Q1 and Q2 2026, alongside steady revenue growth to $402.07B in 2025, highlight operational strength. The stock's valuation appears attractive with a P/E of 23.17 and P/S of 0.27, while a consensus price target of $111.20 suggests significant upside potential. Positive news includes Aetna's 2027 Medicare plan enhancements and a declared quarterly dividend.
The outlook for CVS remains positive, driven by earnings momentum and strategic initiatives in healthcare services. Key risks include reimbursement pressures and regulatory scrutiny, but Wall Street's 85% buy rating and institutional interest underscore confidence. Investors should weigh the stock's growth prospects against margin volatility and debt levels, with the current price offering a favorable entry point relative to targets.
Roblox (RBLX) trades at $46.41, up 1.87% with bullish technical indicators and strong support at $45. The company shows impressive revenue growth from $2.2B in 2022 to $4.89B in 2025, though it remains unprofitable with a -17.61% net margin. Recent earnings have consistently beaten expectations, and operating cash flow improved significantly to $1.8B in 2025.
While analyst sentiment is mixed with 42% buy ratings, the consensus price target of $50.85 suggests 9.6% upside potential. Key risks include persistent losses, high P/B ratio of 213.94, and recent Jefferies downgrade citing bookings concerns. The stock's trajectory depends on continued user growth and path to profitability.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or experiences) for other players. The firm effectively offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning revenue in multiple places while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers then creating new games or franchises. Roblox is increasingly focused on creating a metaverse that moves beyond games toward experiences like concerts, education, and even business management.
Read more on RBLX →